Skip to main
ATHA
ATHA logo

Athira Pharma (ATHA)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Athira Pharma (ATHA) Stock

About Athira Pharma (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Market cap$15.36M
Yesterday's volume8.38K
Revenue (TTM)
Avg. daily volume33.02K
EBITDA (TTM)-$38.34M
Open$3.87
Price / earnings ratio-0.40x
Yesterday's range$3.81 - $3.97
Debt / equity3.4x
52 week range$2.2 - $6.68
5 year debt / equity0.85x
Beta (LTM)1.08x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio9.7x
Ex-dividend date
Next earningsFeb 26, 2026
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for ATHA stock is $15.37M

The current P/E ratio for ATHA stock is -0.4

The 52-week high for ATHA stock is $6.68. The current ATHA stock price $undefined is 100.00% below its 52-week high

The 52-week low for ATHA stock is $2.20. The current ATHA stock price $undefined has increased 100.00% from its 52-week low

No, the ATHA stock does not pay dividends to its shareholders

How to buy ATHA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ATHA stock

    Navigate to the Explore page. Then, type ATHA into the search bar. When you see ATHA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ATHA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Athira Pharma Stock Earnings

The value each ATHA share was expected to gain vs. the value that each ATHA share actually gained.

Athira Pharma (ATHA) reported Q3 2025 earnings per share (EPS) of -$1.68, missing estimates of -$0.80 by 110.00%. In the same quarter last year, Athira Pharma's earnings per share (EPS) was -$7.50. Athira Pharma is expected to release next earnings on 02/26/2026, with an earnings per share (EPS) estimate of -$0.42.

Buy Athira Pharma (ATHA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.